CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Benefits of Outsourcing Regulatory Compliance Services for Chemical Formulations

Benefits of Outsourcing Regulatory...

Key Regulatory Compliance Challenges Facing Life Science Organizations

Key Regulatory Compliance Challenges...

Advarra Offers Cloud-Based Secure Document Exchange To Boost Startup

Advarra Offers Cloud-Based Secure...

Criterion Edge Named Company Of The Year By Life Sciences Review

Criterion Edge Named Company Of The...

Life Sciences Must Prioritize Business Validation

Life Sciences Must Prioritize...

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to...

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a...

Is 2022 the Developmental Phase of Life Sciences?

Is 2022 the Developmental Phase of...

Benefits of Outsourcing Regulatory Compliance Services for Chemical Formulations

Benefits of Outsourcing Regulatory...

Key Regulatory Compliance Challenges Facing Life Science Organizations

Key Regulatory Compliance Challenges...

Advarra Offers Cloud-Based Secure Document Exchange To Boost Startup

Advarra Offers Cloud-Based Secure...

Criterion Edge Named Company Of The Year By Life Sciences Review

Criterion Edge Named Company Of The...

Life Sciences Must Prioritize Business Validation

Life Sciences Must Prioritize...

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to...

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a...

Is 2022 the Developmental Phase of Life Sciences?

Is 2022 the Developmental Phase of...

What is the Need for Compliance Management in Life Science Companies

Life Sciences Review | Tuesday, December 07, 2021
Tweet

Non-compliance results in increased secondary expenses. Life Sciences companies must comply with the regulatory environment to resolve this.


Fremont, CA: Non-compliance leads to sky high secondary expenses, such as non-released stocks, product recalls, and other issues, as well as concerns with authorities suspending production. To address this, Life Sciences organizations must shorten time-to-market, reduce costs, and improve business models while remaining competitive and adhering to a tumultuous regulatory environment. Life sciences organizations operating in a GXP-regulated environment must ensure that their Enterprise systems supporting critical business activities are always compliant.


The need for compliance management in life science companies:


Enterprise systems are continuously changing due to new business requirements, periodic software/infrastructure updates, and other factors that must be managed through a strong change management process to maintain compliance. Updates happen every quarter, especially for firms using Cloud Applications, and the changes must be regression-tested and authenticated to preserve compliance. All changes to the systems must be verified and qualified to fulfill the Computer Systems Validation criteria to ensure continued compliance in the United States under FDA 21 CFR Part 11 rules. Computer System Validation (CSV) is a documented procedure for ensuring that a computer system performs exactly as it is intended in a consistent and repeatable manner. Authorized SOPs govern all system changes with defined processes and controls.


 


Changes to specifications and systems are reviewed and approved as part of the Validation process. Planned minor and major releases and unanticipated Emergency Fixes are all part of the Enterprise platforms' ongoing evolution. There are also important project-driven changes, such as modernizing or expanding the current footprint. The events that trigger the change must be evaluated for their influence on the Core Business Process, and any new functionality must be enabled before the scope of Testing can be determined and test execution scheduled. While it's critical to include regression testing and a formal validation procedure to ensure continuous compliance as the release cycle evolves, it's also critical to avoid slowing down Time-to-Market when delivering changes to production.


Weekly Brief

loading
Top 10 Regulatory Services Companies – 2023
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/what-is-the-need-for-compliance-management-in-life-science-companies-nwid-657.html